Sermonix Pharmaceuticals Alternatives & Competitors
12 companies similar to Sermonix Pharmaceuticals — Passion and purpose in women’s oncology
Companies similar to Sermonix Pharmaceuticals
Alterome Therapeutics, Inc
To Life!
San Diego, United States
Prelude Therapeutics
Precision Oncology, Redefined.
Wilmington, United States
Arcellx
Arcellx is a clinical-stage biotechnology company based in Redwood City, California
Redwood City, United Stat...
Track all Sermonix Pharmaceuticals competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
BeyondSpring
Based in Duncan, South Carolina, we are a pioneering biotechnology company dedicated to ad...
New York, United States
Biodexa Pharmaceuticals PLC
Advancing Medicines for a Brighter Future
Cardiff, United Kingdom
Emmaus Life Sciences, Inc
Improving the lives of people with rare disease.
Torrance, United States
Bexion Pharmaceuticals
Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments...
Covington, United States
ADC Therapeutics
Innovating Science. Inspiring Hope.
Lausanne, Switzerland
iOmx Therapeutics AG
Developing next-generation targeted cancer immunotherapy treatments
Germany
ImmunoMet Therapeutics, Inc.
Targeting Metabolic Reprogramming in Fibrosis and Oncology
About Sermonix Pharmaceuticals
Sermonix Pharmaceuticals is spearheading innovation in women's oncology with a mission underscored by its slogan, "Passion and purpose in women’s oncology." Founded in 2014 by David Portman, MD, the company is a prominent player in the Biopharma and Pharmaceutical industries, with its headquarters in the United States....
Development of Oncology Pharmaceuticals, Clinical Studies and Trials, Commercialization of Women's Cancer Treatments, Research on ESR1 Mutation
Postmenopausal Women with Breast Cancer, Premenopausal Women on Ovarian Suppression, Oncologists and Healthcare Professionals, Pharmaceutical Partners
Women's Health, Oncology, ESR1 Mutation, Metastatic Breast Cancer, Gynecological Cancers, Targeted Therapeutics, Endocrine Agent, ER+/HER2- Breast Cancer, Selective Estrogen Receptor Modulator, Vulvovaginal Atrophy, Post-Menopausal Osteoporosis, Pharmaceutical Development, Late-Stage Product Commercialization, Clinical Research, Lasofoxifene
B2B, B2D
Product Sales, Licensing, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Sermonix Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Sermonix Pharmaceuticals on 11 Mar 2026. The 12 companies listed here were last checked between 27 Nov 2025 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
